Figure 8.
Figure 8. Expression of sialyl 6-sulfo Lex and related determinants on human peripheral leukocytes and in the skin. (A) Freshly isolated human peripheral leukocytes from a healthy donor were stained for sialyl 6-sulfo Lex (G152), CLA (HECA-452) variant sialyl Lex (2F3), and conventional sialyl Lex (CXLEX-1). Gr indicates granulocytes; Mo, monocytes; Ly, lymphocytes. (B-C) Distribution of CLA- and sialyl 6-sulfo Lex–positive lymphoid cells in the normal skin, as ascertained by immunohistochemistry. Note that HECA-452 (B) is reactive to keratinizing and parakeratinizing squamous epithelial cells (arrows) in addition to lymphoid cells, whereas sialyl 6-sulfo Lex is expressed only in lymphoid cells (C).

Expression of sialyl 6-sulfo Lex and related determinants on human peripheral leukocytes and in the skin. (A) Freshly isolated human peripheral leukocytes from a healthy donor were stained for sialyl 6-sulfo Lex (G152), CLA (HECA-452) variant sialyl Lex (2F3), and conventional sialyl Lex (CXLEX-1). Gr indicates granulocytes; Mo, monocytes; Ly, lymphocytes. (B-C) Distribution of CLA- and sialyl 6-sulfo Lex–positive lymphoid cells in the normal skin, as ascertained by immunohistochemistry. Note that HECA-452 (B) is reactive to keratinizing and parakeratinizing squamous epithelial cells (arrows) in addition to lymphoid cells, whereas sialyl 6-sulfo Lex is expressed only in lymphoid cells (C).

Close Modal

or Create an Account

Close Modal
Close Modal